Abstract:Objective: To explore the role of spinal Notch signaling pathway in the development of chemotherapy-induced neuropathic pain. Methods: 40 Sprague-Dawley rats with intrathecal catheterization were picked out and divided into 4 groups: control group, VCR group, repeated administration of DAPT+VCR group, single administration of DAPT+VCR group. Vincristine (125 μg/kg, i.p.) was administrated on alternate days to establish chemotherapy-induced neuropathic pain model in rats. Intrathecal administration (50 μg, 1 μL, i.t.) of DAPT ( inhibitor of Notch signaling pathway) to DAPT group from D0 to D7 (define the first administration of vincristine as D1). The other groups received the same volume of vehicle. Electronic vonfrey , thermal radiation and cold anesthesiometer were used to measure the mechanical paw withdrawl threshold, thermal withdrawl latency and cold paw withdrawl threshold of rats. The expression of NICD (activation markers of Notch signaling pathway) was detected by immunohistochemistry. The expression of NICD protein in the spinal cord was detected by western-blot. The expression of Hes1 mRNA was detected by RT-PCR. Results: Compared with the control group, the pain threshold decreased and the expression of NICD, Hes1 mRNA increased in VCR group (P<0.01).Compared with the VCR group, the pain threshold increased and the expression of NICD, Hes1 mRNA decreased in DAPT+VCR groups (P<0.05 or P<0.01). Conclusion: Spinal Notch signaling pathway may mediate the development of chemotherapy-induced neuropathic pain in rats.